India’s healthcare and pharmacy retail ecosystem is witnessing another important growth story as Mumbai-based Figtree Pharmacy raises seed funding from AJVC Fund and other investors. The investment highlights growing investor confidence in India’s evolving D2C ecosystem India, where healthcare-focused startups are increasingly building modern, technology-led, neighborhood-driven pharmacy models for urban consumers.
Founded in 2025 by former Nomura healthcare analyst Adrit Chaturvedi and Flipspaces’ Yatin Sharma, Figtree Pharmacy is emerging as one of the latest D2C startups rethinking how pharmacy retail operates in India. Unlike traditional large-format chemist stores, the company focuses on compact neighborhood pharmacies designed around hyperlocal demand, faster accessibility, convenience, curated inventory, and repeat consumer engagement.
The fresh capital will be used to strengthen logistics infrastructure, upgrade the company’s technology systems, launch private-label medicines, and expand its retail footprint across India. As part of its D2C expansion plans, Figtree Pharmacy aims to scale its network to 25 stores, reinforcing its position in India’s fast-growing healthcare and wellness-focused D2C business India landscape.
The startup currently operates four stores in Mumbai across Bandra, Altamount Road, and Babulnath, along with one store in Delhi’s ASIAD Village. Another outlet is expected to launch soon in Greater Kailash II, reflecting the company’s focus on premium urban clusters and high-frequency healthcare consumption zones.
Figtree Pharmacy’s early traction reflects broader D2C market trends 2025, where convenience, trust, technology integration, and personalized service are becoming central to consumer healthcare experiences. According to the company, over 90 percent of its sales come from repeat customers, while its average order value exceeds ₹1,000 — a strong indicator of customer retention and growing consumer trust in the platform.
The development also adds momentum to India’s growing D2C funding news ecosystem, particularly within healthcare, wellness, and consumer infrastructure categories. Investors are increasingly backing scalable, operationally efficient, and digitally enabled D2C brands India that combine offline accessibility with modern technology and data-driven supply chain systems.
AJVC Fund, led by Aviral Bhatnagar, continues to strengthen its presence across India’s startup ecosystem through investments in early-stage ventures spanning healthcare, fintech, AI, consumer brands, and digital infrastructure. Its portfolio already includes startups such as Bubble Me, Finanjo, Mindcase, Care Dale, HandyPanda, Multibagg AI, Mithila Foods, Chop Finance, Gaadi Mech, and TruFides AI — reflecting growing investor appetite for emerging D2C startup news and scalable consumer-first business models.
Figtree Pharmacy’s model also aligns with broader changes happening across India’s healthcare retail sector. Consumers today increasingly prefer organized, reliable, and digitally integrated healthcare purchasing experiences. This shift is accelerating demand for omnichannel D2C strategy models where physical accessibility combines with technology-enabled convenience, inventory optimization, and faster service delivery.
The company’s focus on private-label medicines also reflects a growing trend among modern D2C brands scaling in 2025. Across categories ranging from D2C beauty and skincare India to D2C wellness startups and healthcare-focused consumer businesses, brands are increasingly using private-label strategies to improve margins, build customer loyalty, and strengthen long-term brand differentiation.
India’s healthcare and pharmacy market continues to present massive opportunities for organized retail expansion. Rising healthcare awareness, increasing chronic care consumption, digital adoption, urbanization, and preventive wellness spending are driving rapid transformation across the sector. As D2C consumer behavior India evolves, consumers are prioritizing convenience-led healthcare access, trusted neighborhood fulfillment, and technology-enabled service experiences.
Figtree Pharmacy’s compact store strategy, repeat-customer-driven model, and technology-led operations position it strongly within India’s emerging healthcare-focused D2C ecosystem India. The company’s capital-efficient retail expansion strategy also reflects how modern D2C business model India startups are balancing offline retail growth with operational scalability.
As Indian D2C updates continue showcasing rapid innovation across healthcare, wellness, retail, and consumer services, Figtree Pharmacy represents a new generation of healthcare-focused VC-backed D2C brands building localized, high-trust, and digitally integrated pharmacy networks for India’s growing urban consumer base.
